Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1989 1
1991 1
2017 1
2018 1
2019 2
2021 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Asymmetric cell division safeguards memory CD8 T cell development.
Gräbnitz F, Stark D, Shlesinger D, Petkidis A, Borsa M, Yermanos A, Carr A, Barandun N, Wehling A, Balaz M, Schroeder T, Oxenius A. Gräbnitz F, et al. Cell Rep. 2023 May 30;42(5):112468. doi: 10.1016/j.celrep.2023.112468. Epub 2023 May 12. Cell Rep. 2023. PMID: 37178119 Free article.
Light-mediated discovery of surfaceome nanoscale organization and intercellular receptor interaction networks.
Müller M, Gräbnitz F, Barandun N, Shen Y, Wendt F, Steiner SN, Severin Y, Vetterli SU, Mondal M, Prudent JR, Hofmann R, van Oostrum M, Sarott RC, Nesvizhskii AI, Carreira EM, Bode JW, Snijder B, Robinson JA, Loessner MJ, Oxenius A, Wollscheid B. Müller M, et al. Among authors: grabnitz f. Nat Commun. 2021 Dec 2;12(1):7036. doi: 10.1038/s41467-021-27280-x. Nat Commun. 2021. PMID: 34857745 Free PMC article.
Asymmetric cell division shapes naive and virtual memory T-cell immunity during ageing.
Borsa M, Barandun N, Gräbnitz F, Barnstorf I, Baumann NS, Pallmer K, Baumann S, Stark D, Balaz M, Oetiker N, Wagen F, Wolfrum C, Simon AK, Joller N, Barral Y, Spörri R, Oxenius A. Borsa M, et al. Among authors: grabnitz f. Nat Commun. 2021 May 11;12(1):2715. doi: 10.1038/s41467-021-22954-y. Nat Commun. 2021. PMID: 33976157 Free PMC article.
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies.
Medina-Echeverz J, Hinterberger M, Testori M, Geiger M, Giessel R, Bathke B, Kassub R, Gräbnitz F, Fiore G, Wennier ST, Chaplin P, Suter M, Hochrein H, Lauterbach H. Medina-Echeverz J, et al. Among authors: grabnitz f. Nat Commun. 2019 Nov 6;10(1):5041. doi: 10.1038/s41467-019-12998-6. Nat Commun. 2019. PMID: 31695037 Free PMC article.
12 results